Toxicosis in dogs exposed to Clostridium perfringens type A.
Tribe
G W
GW
Kerr
M G
MG
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000009:adverse effects; D002415:Cats; D003015:Clostridium Infections / Q000188:drug therapy / Q000662:veterinary*; D003016:Clostridium perfringens / Q000302:isolation & purification / Q000472:pathogenicity*; D003937:Diagnosis, Differential; D004064:Digestive System / Q000382:microbiology; D004283:Dog Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D004285:Dogs; D005243:Feces / Q000382:microbiology; D006460:Hemolysin Proteins
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D006460:Hemolysin Proteins; C020452:Clostridium perfringens theta-toxin